000 01300 a2200409 4500
005 20250514001134.0
264 0 _c20010809
008 200108s 0 0 eng d
022 _a0269-9370
024 7 _a10.1097/00002030-200104130-00021
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCattelan, A M
245 0 0 _aIndinavir and systemic hypertension.
_h[electronic resource]
260 _bAIDS (London, England)
_cApr 2001
300 _a805-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aCohort Studies
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV Protease Inhibitors
_xadverse effects
650 0 4 _aHumans
650 0 4 _aHypertension
_xchemically induced
650 0 4 _aIndinavir
_xadverse effects
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
650 0 4 _aStatistics, Nonparametric
650 0 4 _aViral Load
700 1 _aTrevenzoli, M
700 1 _aSasset, L
700 1 _aRinaldi, L
700 1 _aBalasso, V
700 1 _aCadrobbi, P
773 0 _tAIDS (London, England)
_gvol. 15
_gno. 6
_gp. 805-7
856 4 0 _uhttps://doi.org/10.1097/00002030-200104130-00021
_zAvailable from publisher's website
999 _c11303587
_d11303587